vTv Therapeutics/$VTVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About vTv Therapeutics
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Ticker
$VTVT
Sector
Primary listing
Employees
23
Headquarters
Website
vTv Therapeutics Metrics
BasicAdvanced
$105M
-
-$3.00
0.57
-
Price and volume
Market cap
$105M
Beta
0.57
52-week high
$26.99
52-week low
$12.62
Average daily volume
2.8K
Financial strength
Current ratio
4.981
Quick ratio
4.896
Total debt to equity
3.285
Profitability
EBITDA (TTM)
-25.566
Gross margin (TTM)
-69,294.12%
Net profit margin (TTM)
-115,029.41%
Operating margin (TTM)
-150,717.65%
Management effectiveness
Return on assets (TTM)
-43.93%
Return on equity (TTM)
-209.04%
Valuation
Price to revenue (TTM)
6,132.618
Price to book
15.16
Price to tangible book (TTM)
15.16
Price to free cash flow (TTM)
-4.732
Free cash flow yield (TTM)
-21.13%
Free cash flow per share (TTM)
-3.381
Growth
Revenue change (TTM)
-98.30%
Earnings per share change (TTM)
-46.56%
3-year revenue growth (CAGR)
-84.98%
10-year revenue growth (CAGR)
-36.08%
3-year earnings per share growth (CAGR)
-35.21%
10-year earnings per share growth (CAGR)
-7.53%
What the Analysts think about vTv Therapeutics
Analyst ratings (Buy, Hold, Sell) for vTv Therapeutics stock.
vTv Therapeutics Financial Performance
Revenues and expenses
vTv Therapeutics Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for vTv Therapeutics stock?
vTv Therapeutics (VTVT) has a market cap of $105M as of August 25, 2025.
What is the P/E ratio for vTv Therapeutics stock?
The price to earnings (P/E) ratio for vTv Therapeutics (VTVT) stock is 0 as of August 25, 2025.
Does vTv Therapeutics stock pay dividends?
No, vTv Therapeutics (VTVT) stock does not pay dividends to its shareholders as of August 25, 2025.
When is the next vTv Therapeutics dividend payment date?
vTv Therapeutics (VTVT) stock does not pay dividends to its shareholders.
What is the beta indicator for vTv Therapeutics?
vTv Therapeutics (VTVT) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.